rxstat › Classes › Blood Glucose Lowering Drugs, Excl. Insulins

Blood Glucose Lowering Drugs, Excl. Insulins: shortage status in Canada

10 of the 20 blood glucose lowering drugs, excl. insulins rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Canagliflozin Widespread shortage 2 of 4 reported products affected · est. return Jan 8, 2027 Dapagliflozin Partial shortage 4 of 11 reported products affected Dapagliflozin Metformin (Xigduo) Partial shortage 2 of 6 reported products affected · est. return Dec 4, 2026 Gliclazide (Diamicron Mr) Partial shortage 2 of 20 reported products affected Metformin (Glucophage) Partial shortage 3 of 33 reported products affected Metformin Sitagliptin (Janumet) Partial shortage 7 of 23 reported products affected · est. return Jul 31, 2026 Pioglitazone (Actos) Partial shortage 5 of 36 reported products affected Repaglinide (Gluconorm) Partial shortage 6 of 21 reported products affected · est. return Sep 4, 2026 Saxagliptin Partial shortage 1 of 4 reported products affected Sitagliptin (Januvia) Partial shortage 11 of 24 reported products affected · est. return Jan 7, 2027 Glyburide (Diabeta) Shortage anticipated 0 of 10 reported products affected Acarbose (Glucobay) Discontinued 0 of 2 reported products affected Chlorpropamide Discontinued 0 of 2 reported products affected Dulaglutide (Trulicity) No current shortage Exenatide (Byetta) Discontinued 0 of 3 reported products affected Linagliptin Empagliflozin (Glyxambi) Discontinued 0 of 2 reported products affected Liraglutide (Victoza) No current shortage Metformin Rosiglitazone (Avandamet) Discontinued 0 of 4 reported products affected Metformin Saxagliptin (Komboglyze) Discontinued 0 of 3 reported products affected Tolbutamide Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.